STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Larimar Therapeutics, Inc.

Filed

January 20, 2022

Period of Report

January 18, 2022

Accession Number

0001062993-22-001319